Justin Chakma, Chief Business Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 50,000 shares at $13.15 ($658K) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Open-market sale of $658k SPRY by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SPRY | SELL | 2024-12-06 | $2.7M | — | Filing → |
| SPRY | SELL | 2024-12-04 | $1.2M | — | Filing → |
| SPRY | SELL | 2024-11-27 | $2.0M | — | Filing → |